H-CPR QCDR

Improving the Quality of Hospital-Based Care

We are dedicated to improving the quality of hospital-based care across the country by reporting and sharing performance and quality data. We believe that direct provider feedback on performance and quality indicators improves patient care.

The Hospital Medicine Qualified Clinical Data Registry (H-CPR) has expertise in Hospital Medicine, Critical Care, Long-Term and Post-Acute Care, with clinical expertise in measure development and in collaboration with specialty societies such as Society of Hospital Medicine (SHM).

Hospital Medicine Qualified Clinical Data Registry (H-CPR)

MedAmerica (d/b/a Vituity) has been approved to become a Qualified Clinical Data Registry (QCDR) by the Centers for Medicare and Medicaid Services (CMS). The Hospitalist – Clinical Performance Registry (H-CPR) supports all MIPS Clinical Quality Measures (CQMs), Promoting Interoperability Measures, and Improvement Activities. H-CPR also supports MIPS Value Pathway (MVP) -Advancing Care for Heart Disease. Additionally, the QCDR measures supported by the Hospitalist-Clinical Performance Registry (H-CPR) are listed below.

H-CPR QCDR Measures

View the detailed measure specifications for the Non-MIPS QCDR measures.

(Updated December 2023)

Measure #	Measure Title	Hospitalist Measures	Post-Acute Care Measures	Critical Care Measures
HCPR20	Clostridium Difficile – Risk Assessment and Plan of Care	✓		✓
HCPR23	Avoidance of Echocardiogram and Carotid Ultrasound for Syncope	✓		✓
HCPR24	Appropriate Utilization of Vancomycin for Cellulitis	✓		✓
HCPR25	Physician’s Orders for Life-Sustaining Treatment (POLST) Form	✓	✓	✓
HCPR26	Heart Failure (HF): SGLT-2 Inhibitor Therapy for Left Ventricular Systolic Dysfunction (LVSD)	✓		✓
HCPR27	Point-of-Care Ultrasound: Evaluation for Pneumothorax after Central Venous Catheter (CVC) Placement	✓		✓
ECPR39	Avoid Head CT for Patients with Uncomplicated Syncope	✓		✓
ECPR51	Discharge Prescription of Naloxone after Opioid Poisoning or Overdose	✓
ECPR56	Opioid Withdrawal: Initiation of Medication-Assisted Treatment (MAT) and Referral to Outpatient Opioid Treatment	✓
ECPR58	Patient-Reported Understanding of Discharge Diagnosis and Plan of Care	✓
ECPR59	Patient Reported Trust in Provider	✓

View measure specifications from previous years:

2022
2023

H-CPR Recommended MIPS Measures

Measure #	Measure Title
5	Heart Failure: Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
6	Heart Failure: Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
7	Beta-Blocker Therapy-Prior MI or LVEF ≤40%
8	Heart Failure: Beta- Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
47	Advanced Care Plan
130	Documentation of Current Medications in the Medical Record
155	Falls: Plan of Care

Learn More

Learn More

Questions?

Questions?

Partnering to improve patient lives